An indication for a pacemaker or implantable cardioverter-defibrillator (ICD) in a patient with an intracardiac shunt requires a balancing of the risks and benefits associated with a transvenous ...

Patients who received a leadless pacemaker had similar rates of acute complications and survival at 30 days as those who received a transvenous VVI pacemaker, according to data presented at the ...

A 67-year-old man with acute anterolateral myocardial infarction had recurrent ventricular fibrillation that required insertion of temporary pacemaker. When a permanent pacemaker was inserted stable ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Complications related to transvenous pacemakers have ...

The implantable defibrillator with subcutaneous leads, designed in part to minimize the risk for potentially serious lead-related complications, has reached a milestone by turning in a "noninferior" ...

Patients with intracardiac shunts might at some point require a pacemaker or an implantable cardioverter–defibrillator (ICD). These patients may have numerous thrombotic risk factors, however, and ...

Despite being at higher risk of complications overall, Medicare beneficiaries who receive a Micra leadless pacemaker (Medtronic) fare better than those implanted with traditional transvenous systems, ...

There are unique technical issues that must be considered with the implantation of devices in small patients and those with CHD. Although most centers report low complication rates of complications in ...

In a typical population of patients requiring implantable cardioverter-defibrillator (ICD) therapy without pacing, mostly for the primary prevention of sudden cardiac death, a subcutaneous ICD (S-ICD; ...

SINCE the introduction of permanent transvenous cardiac pacemakers for the treatment of complete heart block in 1963,§ 18 Medtronic¶ pacemaker units have been inserted via the jugular approach in 16 ...

MENLO PARK, Calif.--(BUSINESS WIRE)--BioTrace Medical, Inc., the leader in innovative temporary cardiac pacing technology, today announced the company’s Tempo ® Temporary Pacing Lead was featured in a ...